Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

NCT01794182 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke
Malignant Edema

Interventions

DRUG: Glyburide for Injection
DRUG: Placebo

Sponsor

Remedy Pharmaceuticals, Inc.